Metformin therapy in a hyperandrogenic anovulatory mutant murine model with polycystic ovarian syndrome characteristics improves oocyte maturity during superovulation.
about
Impaired oocyte quality induced by dehydroepiandrosterone is partially rescued by metformin treatmentDoes metformin improve in vitro maturation and ultrastructure of oocytes retrieved from estradiol valerate polycystic ovary syndrome-induced rats.Both diet and gene mutation induced obesity affect oocyte quality in mice.The mechanism of mTOR (mammalian target of rapamycin) in a mouse model of polycystic ovary syndrome (PCOS).Rodent models for human polycystic ovary syndrome.IGF-1R and Leptin Expression Profile and the Effects of Metformin Treatment on Metabolic and Endocrine Parameters in PCOS Mice.
P2860
Metformin therapy in a hyperandrogenic anovulatory mutant murine model with polycystic ovarian syndrome characteristics improves oocyte maturity during superovulation.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Metformin therapy in a hyperan ...... aturity during superovulation.
@ast
Metformin therapy in a hyperan ...... aturity during superovulation.
@en
type
label
Metformin therapy in a hyperan ...... aturity during superovulation.
@ast
Metformin therapy in a hyperan ...... aturity during superovulation.
@en
prefLabel
Metformin therapy in a hyperan ...... aturity during superovulation.
@ast
Metformin therapy in a hyperan ...... aturity during superovulation.
@en
P2093
P2860
P356
P1476
Metformin therapy in a hyperan ...... aturity during superovulation.
@en
P2093
Aaron K Styer
Bo R Rueda
Hojoon Lee
Joseph O Doyle
Lankai Guo
Mary E Sabatini
Maureen P Lynch
P2860
P2888
P356
10.1186/1757-2215-4-8
P577
2011-05-23T00:00:00Z
P5875
P6179
1010186387